Elaia Gets A Big Investment To Help Deep Tech Startups
Elaia, a European venture capital firm, has announced the final close of its 3rd deep tech seed fund. The new car, called DTS3, is now worth €134 million. The fund makes Elaia’s previous deep tech projects twice as big.
The investment fund will focus on tech companies in Europe that are just starting out. It is mostly about business-to-business startups that are in the pre-seed or seed stage. A lot of the time, these companies come from academic research institutions.
Source: TNW – Website
Fund Strengthens Link Between Research And Industry
Elaia set up the new fund to make it easier for scientific research and business innovation to work together. The company worked with top schools like PSL Université INRIA and CNRS. The Barcelona Supercomputing Center and the Max Planck Foundation are also working together.
The goal of these partnerships is to help researchers turn scientific breakthroughs into businesses that can grow. Universities and labs are often the places where new technologies are made. Venture capital money helps these discoveries get to the market.
Elaia Uses Scientific Breakthroughs To Build Companies
For more than 20 years, the venture firm has helped tech companies that are based on research discoveries. Previous investments led to a number of well-known success stories in the fields of biotechnology and computing. These results show how Elaia invests.
For instance, Aqemia uses cutting-edge computer techniques to speed up research on new drugs. Alice and Bob are working on quantum computing technologies that can handle errors. RadNet later bought Gleamer’s artificial intelligence medical imaging tools.
Recommended Article: Tanzania Expands Science And Innovation Investment Strategy
Early Investments Already Spread Across Europe
The fund just closed its last investment, but investments started earlier. Elaia has already backed 11 startups since its first round of funding in March 2024. These businesses work in the fields of computing, life sciences, and industrial technologies.
The portfolio shows how varied Europe’s scientific innovation ecosystem is. Research clusters in many countries give rise to startups. Every company deals with big tech problems.
Fusion Energy Startup Talks About Big Plans
Proxima Fusion, which is based in Germany, was one of the fund’s first investments. The company is working on fusion power plants based on stellarators that will provide stable, clean energy. Fusion energy for business could change the way electricity is made around the world.
If it works, the technology could help Europe become the leader in the global fusion energy industry. Researchers want to put operational systems into use in the 2030s. These kinds of projects show how big the fund’s goal for innovation is.
AI And Biotech Companies Join Portfolio
The portfolio also includes new businesses that are working on biotechnology, industrial automation, and artificial intelligence. French startup GetVocal makes conversational AI systems for business customer service that can be audited. Companies can use both automated and human help with this technology.
Biophta is another company that makes a medical device that can take the place of regular eye treatments. Its eye insert is meant to help with problems like glaucoma and macular edema. Mimic, which is based in Switzerland, works on smart automation for factories.
The Pan European Strategy Aims At Future Technologies
Elaia wants to put between €1 million and €13 million into each startup. The fund will work in important research centers in France, Germany, Spain, the UK, and Switzerland. Investors may also put money into new innovation clusters that are popping up all over Europe.
The strategy is based on 3 main technology themes that will shape industries in the future. These fields include research in life sciences, computing technologies, and industrial innovation. Elaia is still growing Europe’s deep tech ecosystem with more than €1 billion in assets.
